Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for NUMIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
May 31, 2026 51.16%
February 28, 2026 52.66%
November 30, 2025 31.83%
August 31, 2025 55.70%
May 31, 2025 43.32%
February 28, 2025 27.26%
November 30, 2024 47.51%
August 31, 2024 26.63%
May 31, 2024 -17.27%
February 29, 2024 38.38%
November 30, 2023 25.20%
August 31, 2023 23.40%
May 31, 2023 27.99%
Date Value
February 28, 2023 31.29%
November 30, 2022 34.49%
August 31, 2022 14.96%
May 31, 2022 -9.03%
February 28, 2022 12.71%
November 30, 2021 -0.11%
August 31, 2021 -36.01%
May 31, 2021 -16.33%
February 28, 2021 -55.62%
November 30, 2020 -56.44%
August 31, 2020 -51.29%
May 31, 2020 -73.66%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 88.57%
Edesa Biotech, Inc. --
CNBX Pharmaceuticals, Inc. --
GB Sciences, Inc. --
Invion Ltd. --

Gross Profit Margin (Quarterly) Related Metrics